
|Videos|June 12, 2019
Dr. Rimas Lukas on Controlled Interleukin-12 Combined With a PD-1 Inhibitor in Recurrent Glioblastoma
Author(s)Rimas V. Lukas, MD
Cancer Network spoke with Rimas V. Lukas, MD, of Northwestern University Feinberg School of Medicine, about the combination of controlled interleukin-12 with a PD-1 inhibitor in recurrent glioblastoma.
Advertisement
Cancer Network spoke with Rimas V. Lukas, MD, of Northwestern University Feinberg School of Medicine, about the combination of controlled interleukin-12 with a PD-1 inhibitor in recurrent glioblastoma.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Exploring The Application of Artificial Intelligence in Radiology Scans
2
Navigating the Surgical Nuances of Inflammatory Breast Cancer and Phyllodes Tumors
3
Indirect Comparison Supports Zanubrutinib Monotherapy in CLL/SLL Care
4
The Weight of Finances on Cancer Care: An Oncologist’s Perspective
5



































